A Study of ADXS-NEO Expressing Personalized Tumor Antigens

Clinical trial NCT03265080 · TERMINATED

Trial details

NCT number: NCT03265080
Sponsor: Advaxis, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colon Cancer Metastatic Head and Neck Cancer Metastatic Metastatic Non-Small Cell Lung Cancer Urothelial Carcinoma Metastatic Melanoma

Start date: 2018-03-28
Primary completion: 2019-10-24
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.